Asfār (tarjome-ye fārsī). Traduction par Moḥammad Ḫvājavī, Tehrān, Mawlā, 1378/1999, 3 vol. : 419 p. + 429 p. + 452 p.
نویسندگان
چکیده
منابع مشابه
Cancer Immunity (10 February 2006) Vol. 6, p. 3
In order to establish a rationale for immunotherapy for lung cancer, we have investigated immunological characteristics of tumorassociated antigens (TAAs) discovered through molecular approaches. Preexisting Abs specific to these predicted TAAs were examined using specimens of lung pleural effusions (LPEs) and sera in non-small cell lung cancer (NSCLC) patients. The novel cancertestis (CT) anti...
متن کاملCancer Immunity (15 January 2013) Vol. 13, p. 3
1Department of Oncology, University Hospital Zürich, Zürich, Switzerland 2CT-Atlantic, Schlieren, Switzerland 3Ludwig Institute for Cancer Research, New York Branch, Memorial Sloan-Kettering Cancer Center, New York, NY, USA 4Experimental Immunology, Immunology Frontier Research Center, Osaka University, Osaka, Japan 5Departments of Cancer Vaccine and Immuno-Gene Therapy, Mie University Graduate...
متن کاملCancer Immunity, Vol. 4, p. 12 (3 November 2004)
The NY-ESO-1 antigen is expressed in a significant proportion of patients with epithelial ovarian cancer (EOC) and appears to be an ideal target for immunotherapy. In order to elucidate the nature of the HLA-DPB1*0401/0402 (DP4+)-restricted CD4+ immune response in patients with NY-ESO-1-expressing EOC, peripheral blood CD4+ T cells from HLA-DP4+ patients were stimulated with the NY-ESO1 epitope...
متن کاملCancer Immunity (6 February 2008) Vol. 8, p. 3
1Ludwig Institute for Cancer Research, New York Branch at Memorial Sloan-Kettering Cancer Center, New York, NY, USA 2The Laboratory of Cell Growth Regulation, Department of Cell Signaling, Institute of Molecular Biology and Genetics, Kyiv, Ukraine 3Department of Biochemistry and Molecular Biology, University College London, London, United Kingdom 4Ludwig Institute for Cancer Research, BioMedica...
متن کاملCancer Immunity (21 February 2007) Vol. 7, p. 3
During the past decade, remarkable progress has been made in understanding the interactions between the immune system and cancer. Importantly, there is growing evidence for the concept of cancer immunosurveillance and immunoediting based on (i) protection against development of spontaneous and chemicallyinduced tumors in animal systems and (ii) identification of targets for immune recognition o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Abstracta Iranica
سال: 2001
ISSN: 0240-8910,1961-960X
DOI: 10.4000/abstractairanica.36915